161 related articles for article (PubMed ID: 14612290)
21. [Evaluation of p53, p21waf1, and PCNA in the diagnosis on lung cancer].
Ding X; Yang J; Hu S; Wu X; Li Q
Zhonghua Liu Xing Bing Xue Za Zhi; 2001 Feb; 22(1):54-7. PubMed ID: 11860847
[TBL] [Abstract][Full Text] [Related]
22. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
Kao JT; Chuah SK; Huang CC; Chen CL; Wang CC; Hung CH; Chen CH; Wang JH; Lu SN; Lee CM; Changchien CS; Hu TH
Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
[TBL] [Abstract][Full Text] [Related]
23. Cell cycle proteins in laryngeal cancer: role in proliferation and prognosis.
Peschos D; Stefanou D; Vougiouklakis T; Assimakopoulos DA; Agnantis NJ
J Exp Clin Cancer Res; 2005 Sep; 24(3):431-7. PubMed ID: 16270530
[TBL] [Abstract][Full Text] [Related]
24. The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma.
Wang LF; Chai CY; Kuo WR; Tai CF; Lee KW; Ho KY
Acta Otolaryngol; 2006 Jul; 126(7):769-74. PubMed ID: 16803719
[TBL] [Abstract][Full Text] [Related]
25. Clinical significance of combination study of apoptotic factors and proliferating cell nuclear antigen in estimating the prognosis of hepatocellular carcinoma.
Osada S; Saji S; Kuno T
J Surg Oncol; 2004 Jan; 85(1):48-54. PubMed ID: 14696087
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of p53 and PCNA expression for occult neck metastases in patients with clinically node-negative oral tongue cancer.
Keum KC; Chung EJ; Koom WS; Cho JH; Cho SH; Choi EC; Lee CG; Suh CO; Kim GE
Otolaryngol Head Neck Surg; 2006 Dec; 135(6):858-64. PubMed ID: 17141074
[TBL] [Abstract][Full Text] [Related]
27. Expression of p27(kip1), Rb protein and proliferating cell nuclear antigen and its relationship with clinicopathology in human pancreatic cancer.
Yue H; Song FL; Zhang N; Feng XL; An TY; Yu JP
Hepatobiliary Pancreat Dis Int; 2003 Feb; 2(1):142-6. PubMed ID: 14607668
[TBL] [Abstract][Full Text] [Related]
28. Intraductal papillary mucinous neoplasms of the pancreas: an analysis of protein expression and clinical features.
Nishikawa N; Kimura Y; Okita K; Zembutsu H; Furuhata T; Katsuramaki T; Kimura S; Asanuma H; Hirata K
J Hepatobiliary Pancreat Surg; 2006; 13(4):327-35. PubMed ID: 16858545
[TBL] [Abstract][Full Text] [Related]
29. The role of immunohistochemistry in histopathological diagnostics of clinically "silent" incidentally detected adrenal masses.
Babinska A; Sworczak K; Wisniewski P; Nałecz A; Jaskiewicz K
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):246-51. PubMed ID: 18393131
[TBL] [Abstract][Full Text] [Related]
30. Expression of Gadd45a and p53 proteins in human pancreatic cancer: potential effects on clinical outcomes.
Dong M; Dong Q; Zhang H; Zhou J; Tian Y; Dong Y
J Surg Oncol; 2007 Mar; 95(4):332-6. PubMed ID: 17230496
[TBL] [Abstract][Full Text] [Related]
31. [Expression of ras oncogene p21 product and proliferating cell nuclear antigen in liver cirrhosis and the correlation with liver cell dysplasia].
Feng Z; He R; Lu Z; Ling Y
Zhonghua Gan Zang Bing Za Zhi; 2000 Dec; 8(6):343-5. PubMed ID: 11135691
[TBL] [Abstract][Full Text] [Related]
32. [Expressions of beta-catenin, p53 and proliferating cell nuclear antigen in the carcinogenesis of colorectal adenoma].
Wu W; Zhang X; Yan X; Wang J; Zhang J; Li Y
Zhonghua Zhong Liu Za Zhi; 2002 May; 24(3):264-7. PubMed ID: 12515622
[TBL] [Abstract][Full Text] [Related]
33. Infrequent expression of p21 is related to altered p53 protein in pancreatic carcinoma.
Hu YX; Watanabe H; Ohtsubo K; Yamaguchi Y; Ha A; Motoo Y; Okai T; Sawabu N
Clin Cancer Res; 1998 May; 4(5):1147-52. PubMed ID: 9607571
[TBL] [Abstract][Full Text] [Related]
34. [Expression of proliferating cell nuclear antigen and tumor suppressor gene P53 in mucoepidermoid carcinoma of salivary glands].
Chen K; Gao Y; Pang S
Zhonghua Kou Qiang Yi Xue Za Zhi; 1996 Sep; 31(5):285-7. PubMed ID: 9592256
[TBL] [Abstract][Full Text] [Related]
35. [Molecular marker as an indicator in presaging prognosis of human lung adenocarcinoma].
Zhou B; Dai X; He A
Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Aug; 19(4):231-3. PubMed ID: 10322679
[TBL] [Abstract][Full Text] [Related]
36. Expression of ras Rb1 and p53 proteins in human breast cancer.
Spandidos DA; Karaiossifidi H; Malliri A; Linardopoulos S; Vassilaros S; Tsikkinis A; Field JK
Anticancer Res; 1992; 12(1):81-9. PubMed ID: 1567185
[TBL] [Abstract][Full Text] [Related]
37. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
[TBL] [Abstract][Full Text] [Related]
38. Expression of p53 and PCNA in cholangiocarcinoma and primary sclerosing cholangitis.
Batheja N; Suriawinata A; Saxena R; Ionescu G; Schwartz M; Thung SN
Mod Pathol; 2000 Dec; 13(12):1265-8. PubMed ID: 11144921
[TBL] [Abstract][Full Text] [Related]
39. [A study on expressions of P53 protein and proliferating cell nuclear antigen in malignant eyelid tumors].
Niu Y; Wang H; Ji J; Lin H; Zhang A
Zhonghua Yan Ke Za Zhi; 1999 Jan; 35(1):36-9, 5. PubMed ID: 11835772
[TBL] [Abstract][Full Text] [Related]
40. Loss of p21 expression is associated with p53 mutations and increased cell proliferation and p27 expression is associated with apoptosis in maxillary sinus squamous cell carcinoma.
Bandoh N; Hayashi T; Takahara M; Kishibe K; Ogino T; Katayama A; Imada M; Nonaka S; Harabuchi Y
Acta Otolaryngol; 2005 Jul; 125(7):779-85. PubMed ID: 16012042
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]